TrialAmerican journal of hematology2009

Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.

Paul M Barr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.